O Diou1, S Greco1, T Beltran1, D Lairez2, J-R Authelin1, D Bazile3. 1. Sanofi Research and Development, Lead Generation to Candidate Realization Platform, 13 Quai Jules Guesde, 94403, Vitry-sur-Seine, France. 2. Laboratoire Léon Brillouin, CEA Saclay, Gif-sur-Yvette Cedex, 91191, France. 3. Sanofi Research and Development, Lead Generation to Candidate Realization Platform, 13 Quai Jules Guesde, 94403, Vitry-sur-Seine, France. Didier.Bazile@sanofi.com.
Abstract
PURPOSE: To study the impact of the size and the structure of the nano-assembly on the drug/particle association, determining the intrinsic partition coefficient, in order to better master the encapsulation and release properties of the carrier. METHODS: An experimental methodology is proposed to characterize the drug/nanoparticle association by mean of a partition coefficient between the PLA-PEG nanoparticles and the suspending aqueous medium, referred to as Kp. The determination was made from apparent values (referred to as Kp (ap)) measured in the presence of solubilizing agents (albumin and hydroxypropyl-βcyclodextrin) and extrapolation to zero concentration. The structure of nanoparticles was investigated by Transmission Electron Microscopy and static light scattering. RESULTS: Depending on the manufacturing process and the PEG length of the copolymer, the nanoparticles structured either as aggregates of copolymer chains or micelles exhibiting significantly different Kp values. CONCLUSION: The methodological tool described here showed that the difference in cabazitaxel/nanoparticle association between aggregates and micelles could be attributed to the difference in PLA-PEG chains packing.
PURPOSE: To study the impact of the size and the structure of the nano-assembly on the drug/particle association, determining the intrinsic partition coefficient, in order to better master the encapsulation and release properties of the carrier. METHODS: An experimental methodology is proposed to characterize the drug/nanoparticle association by mean of a partition coefficient between the PLA-PEG nanoparticles and the suspending aqueous medium, referred to as Kp. The determination was made from apparent values (referred to as Kp (ap)) measured in the presence of solubilizing agents (albumin and hydroxypropyl-βcyclodextrin) and extrapolation to zero concentration. The structure of nanoparticles was investigated by Transmission Electron Microscopy and static light scattering. RESULTS: Depending on the manufacturing process and the PEG length of the copolymer, the nanoparticles structured either as aggregates of copolymer chains or micelles exhibiting significantly different Kp values. CONCLUSION: The methodological tool described here showed that the difference in cabazitaxel/nanoparticle association between aggregates and micelles could be attributed to the difference in PLA-PEG chains packing.
Entities:
Keywords:
PLA-PEG nanoparticle; drug delivery; partition; release; static light scattering
Authors: Stephan T Stern; Jennifer B Hall; Lee L Yu; Laura J Wood; Giulio F Paciotti; Lawrence Tamarkin; Stephen E Long; Scott E McNeil Journal: J Control Release Date: 2010-04-10 Impact factor: 9.776
Authors: Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale Journal: Sci Transl Med Date: 2012-04-04 Impact factor: 17.956
Authors: D V Bazile; C Ropert; P Huve; T Verrecchia; M Marlard; A Frydman; M Veillard; G Spenlehauer Journal: Biomaterials Date: 1992 Impact factor: 12.479
Authors: Rohit Karnik; Frank Gu; Pamela Basto; Christopher Cannizzaro; Lindsey Dean; William Kyei-Manu; Robert Langer; Omid C Farokhzad Journal: Nano Lett Date: 2008-07-26 Impact factor: 11.189
Authors: Dora Mehn; Patrizia Iavicoli; Noelia Cabaleiro; Sven Even Borgos; Fanny Caputo; Otmar Geiss; Luigi Calzolai; François Rossi; Douglas Gilliland Journal: Int J Pharm Date: 2017-03-22 Impact factor: 5.875
Authors: Blanka Halamoda-Kenzaoui; Simon Baconnier; Thierry Bastogne; Didier Bazile; Patrick Boisseau; Gerrit Borchard; Sven Even Borgos; Luigi Calzolai; Karin Cederbrant; Gabriella Di Felice; Tiziana Di Francesco; Marina A Dobrovolskaia; Rogério Gaspar; Belén Gracia; Vincent A Hackley; Lada Leyens; Neill Liptrott; Margriet Park; Anil Patri; Gert Roebben; Matthias Roesslein; René Thürmer; Patricia Urbán; Valérie Zuang; Susanne Bremer-Hoffmann Journal: Regul Toxicol Pharmacol Date: 2019-04-30 Impact factor: 3.271